Bristol Myers Squibb drug sales boost Q2 earnings, guidance

Yahoo Finance Video
8,992 次觀看・4 個月前

Pharmaceutical giant Bristol Myers Squibb (BMY) is getting a stock boost after beating second quarter earnings expectations on the top and bottom lines and raising its full-year guidance.

Yahoo Finance senior health reporter Anjalee Khemlani digs into the earnings report and some of Bristol Myers Squibb's cost-cutting measures.

For more expert insight and the latest market action, click here to watch this full episode of Catalysts.

This post was written by Melanie Riehl